US Stock MarketDetailed Quotes

CVAC CureVac

Watchlist
  • 2.890
  • -0.080-2.69%
Close Mar 21 16:00 ET
  • 2.860
  • -0.030-1.04%
Post 18:50 ET
648.34MMarket Cap5.67P/E (TTM)

CureVac Key Stats

CureVac Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.557M--
--2024/Q4-- / 20.582M--
Nov 12, 20242024/Q3493.900M / 138.328M--
Aug 15, 20242024/Q214.436M / 4.911M--
May 23, 20242024/Q112.373M / 12.889M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.557M--
--2024/Q4-- / 20.582M--
Nov 12, 20242024/Q3493.900M / 138.328M--
Aug 15, 20242024/Q214.436M / 4.911M--
May 23, 20242024/Q112.373M / 12.889M--

Unlock Free Earnings Estimates

CureVac Earnings Reports

Read more

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.